Medable is on a mission to reduce clinical trial timelines by 50 percent. The company's global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/04/20 | $25,000,000 |
GSR Ventures PPD | undisclosed | |
| 11/19/20 | $91,000,000 | Series C |
GSR Ventures PPD Sapphire Ventures Streamlined Ventures | undisclosed |
| 04/15/21 | $78,000,000 |
GSR Ventures Obvious Ventures PPD Sapphire Ventures Streamlined Ventures | undisclosed | |
| 10/26/21 | $304,000,000 | Series D |
Blackstone Growth GSR Ventures Sapphire Ventures Tiger Global Management WTI | undisclosed |
